Prostate Cancer Without Regret: A Smarter Path That Preserves Vitality

Most men are presented with prostate cancer as a narrow set of options.

Biopsy.
Surgery.
Radiation.
Hormone suppression.

According to Dr. Stephen Petteruti, that framing is incomplete—and often harmful.

In his new book Fight Cancer Like a Man, Dr. Petteruti lays out a fundamentally different approach to prostate cancer. One that prioritizes evidence, safety, and long-term vitality rather than fear-driven intervention.

The central message is simple but uncomfortable for conventional medicine.

Guaranteed harm with uncertain benefit is not good care.

Why Conventional Prostate Cancer Treatment Disappoints

Decades of data show a sobering truth. For early-stage prostate cancer, survival rates are nearly identical whether men choose aggressive treatment or do nothing at all.

What differs dramatically is quality of life.

• Urinary incontinence.
• Erectile dysfunction.
• Fatigue.
• Cognitive decline.
• Cardiovascular risk.

Dr. Petteruti explains why these outcomes are not unfortunate side effects, but predictable consequences of treatments that remove or irradiate a gland that often never posed a lethal threat.

When harm is certain and benefit is speculative, medicine must pause.

The Problem With Biopsy-Driven Decisions

Prostate biopsy remains a cornerstone of conventional care, yet it introduces risk without reliably improving outcomes.

Dr. Petteruti challenges the logic directly.

What other cancer is repeatedly pierced, sampled, and then left in place?
What other disease justifies trauma without clear survival advantage?

He explains why biopsy often serves as a psychological trigger rather than a clinical necessity—locking men into treatment pathways they later regret.

A Risk-Based Model Without Tissue Damage

Rather than forcing men into binary decisions, Dr. Petteruti outlines a risk-stratified approach that does not require biopsy.

This model relies on three tools:
• PSA trends
• Prostate Health Index (PHI)
• Prostate MRI with PI-RADS scoring

When these markers remain within defined ranges, cancer risk is low. The priority becomes containment, not destruction.

Cancer cells confined to the gland cannot kill you.

Repurposed Drug Therapy as a Foundation

At the core of this approach is repurposed drug therapy—medications with decades of safety data that alter cancer metabolism and immune behavior without damaging vitality.

Dr. Petteruti discusses why drugs like metformin, sirolimus, doxycycline, low-dose naltrexone, and statins appear repeatedly in cancer research despite lacking commercial backing.

These agents do not promise a cure. They aim to create an internal environment that is inhospitable to cancer while improving overall health.

The collateral benefits matter.

• Lower cardiovascular risk.
• Improved metabolic health.
• Reduced inflammation.
• Preserved testosterone and strength.

Why Castration Is the Wrong Default

Androgen deprivation therapy remains one of the most devastating recommendations men receive.

Dr. Petteruti does not mince words.

Chemical castration guarantees suffering.
It does not guarantee survival.

Fatigue, muscle loss, depression, dementia risk, and cardiovascular disease often appear long before cancer ever becomes life-threatening.

PSA suppression is mistaken for success, but quality of life should be weighed honestly.

When Cancer Progresses Beyond the Gland

Even in more advanced cases, Dr. Petteruti argues that men are not without options.

Bone metastases do not mean immediate collapse.
Progression does not erase the importance of vitality.

He explains when conventional oncology tools may play a supportive role—such as targeted radiation for fracture prevention—while still rejecting unnecessary systemic harm.

Choice Is the Point

This book is not about guarantees.

There are none in life or medicine.

It is about informed choice.
About understanding tradeoffs.
About avoiding regret born from fear and pressure.

Dr. Petteruti invites men to consider a different philosophy.

Live vitally.
Protect your biology.
Make decisions you can stand behind years later.

Fight Cancer Like a Man. Launching February 22

Can't wait? Start familiarizing yourself with Dr. Petteruti's work.

Fight Prostate Cancer Like a Man: Avoid Regret, Reclaim Your Power Using Repurposed Drug Therapy

• Why prostate cancer survival is often unaffected by aggressive treatment
• How to assess risk without biopsy
• The role of repurposed drugs in containment strategies
• Why testosterone preservation matters
• When conventional oncology may still be useful
• How to avoid regret while navigating uncertainty

If you’ve been told your only options involve sacrifice and suffering, this conversation matters.

Watch the full podcast and explore a path that prioritizes clarity, choice, and vitality over fear.